-
The governors square off in a first-of-its-kind debate Thursday. Let's compare the political rivals’ health care positions, showing how their policies helped — or hinder— the health of their states’ residents.
-
The company said that customers in College Station, Texas, can now get prescriptions delivered by a drone within an hour of placing their order.
-
To contain the opioid crisis, agencies have turned to technology to monitor prescription data. Experts have raised questions about how these systems work and worry about their accuracy and potential biases.
-
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development nor their therapeutic value, research shows.
-
A new report by AARP found that the top 25 drugs — covered under Medicare Part D — have almost tripled in price since they first entered the market.
-
Medicare soon will start something it hasn't done in its 58-year history: negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.
-
Supporters say the proposed rules would balance the goals of increasing access to health care and helping prevent medication misuse. Opponents say the rules would make it difficult for some patients — especially those in rural areas — to get care.
-
The judge issued an order granting the FDA's request for a stay and noting that a trial is scheduled in November.
-
Sen. Bernie Sanders’ broad statement on U.S. drug prices doesn’t paint the full picture. Studies we examined generally found that U.S. prices were 2 to 4 times those in other countries, not 10.
-
The House Appropriations Committee on Friday approved a bill that would make a series of changes to regulate PBMs. The Senate unanimously passed its version on Wednesday.